DSIP stands for Delta Sleep-Inducing Peptide, a naturally occurring short peptide originally identified in animal models. It’s made of nine amino acids and is thought to play a role in regulating deep (slow-wave) sleep and circadian rhythm function. It’s also explored for influence on stress, hormonal modulation, and recovery processes.
Research and product descriptions (mostly early/experimental) suggest DSIP may be involved in several physiological processes:
Promotes deep, restorative sleep by potentially enhancing delta wave activity (deep non-REM sleep).
May improve sleep quality, shorten sleep onset latency, and help with overall sleep architecture.
May lower stress hormone (cortisol) levels and encourage a calmer stress response.
Some studies and anecdotal reports link it to mood stabilization and relaxation support.
Has been studied for effects on hormonal regulation (e.g., affecting luteinizing hormone).
Research models suggest neuroprotective and antioxidant activity.
Investigated for possible roles in withdrawal support and pain modulation in animal models.
Dosing is experimental and based on research protocols, not clinical guidelines:
Common range: ~100–300 mcg injected subcutaneously about 30–60 min before bedtime.
Some protocols use alternate-day dosing or cycling rather than daily continuous use
DSIP stands for Delta Sleep-Inducing Peptide, a naturally occurring short peptide originally identified in animal models. It’s made of nine amino acids and is thought to play a role in regulating deep (slow-wave) sleep and circadian rhythm function. It’s also explored for influence on stress, hormonal modulation, and recovery processes.
Research and product descriptions (mostly early/experimental) suggest DSIP may be involved in several physiological processes:
Promotes deep, restorative sleep by potentially enhancing delta wave activity (deep non-REM sleep).
May improve sleep quality, shorten sleep onset latency, and help with overall sleep architecture.
May lower stress hormone (cortisol) levels and encourage a calmer stress response.
Some studies and anecdotal reports link it to mood stabilization and relaxation support.
Has been studied for effects on hormonal regulation (e.g., affecting luteinizing hormone).
Research models suggest neuroprotective and antioxidant activity.
Investigated for possible roles in withdrawal support and pain modulation in animal models.
Dosing is experimental and based on research protocols, not clinical guidelines:
Common range: ~100–300 mcg injected subcutaneously about 30–60 min before bedtime.
Some protocols use alternate-day dosing or cycling rather than daily continuous use
